These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24809778)

  • 1. Direct T cell-tumour interaction triggers TH1 phenotype activation through the modification of the mesenchymal stromal cells transcriptional programme.
    Jin P; Civini S; Zhao Y; De Giorgi V; Ren J; Sabatino M; Jin J; Wang H; Bedognetti D; Marincola F; Stroncek D
    Br J Cancer; 2014 Jun; 110(12):2955-64. PubMed ID: 24809778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microenvironmental cues enhance mesenchymal stem cell-mediated immunomodulation and regulatory T-cell expansion.
    Kadle RL; Abdou SA; Villarreal-Ponce AP; Soares MA; Sultan DL; David JA; Massie J; Rifkin WJ; Rabbani P; Ceradini DJ
    PLoS One; 2018; 13(3):e0193178. PubMed ID: 29513756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially.
    Prasanna SJ; Gopalakrishnan D; Shankar SR; Vasandan AB
    PLoS One; 2010 Feb; 5(2):e9016. PubMed ID: 20126406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact.
    Ciccocioppo R; Cangemi GC; Kruzliak P; Gallia A; Betti E; Badulli C; Martinetti M; Cervio M; Pecci A; Bozzi V; Dionigi P; Visai L; Gurrado A; Alvisi C; Picone C; Monti M; Bernardo ME; Gobbi P; Corazza GR
    Stem Cell Res Ther; 2015 Jul; 6(1):137. PubMed ID: 26206376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IDO-independent suppression of T cell effector function by IFN-γ-licensed human mesenchymal stromal cells.
    Chinnadurai R; Copland IB; Patel SR; Galipeau J
    J Immunol; 2014 Feb; 192(4):1491-501. PubMed ID: 24403533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells use IDO to regulate immunity in tumor microenvironment.
    Ling W; Zhang J; Yuan Z; Ren G; Zhang L; Chen X; Rabson AB; Roberts AI; Wang Y; Shi Y
    Cancer Res; 2014 Mar; 74(5):1576-87. PubMed ID: 24452999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells.
    Yañez R; Oviedo A; Aldea M; Bueren JA; Lamana ML
    Exp Cell Res; 2010 Nov; 316(19):3109-23. PubMed ID: 20804749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of indoleamine-2,3 dioxygenase in bone marrow stromal cells inhibits myeloma cell growth.
    Pfeifer S; Schreder M; Bolomsky A; Graffi S; Fuchs D; Sahota SS; Ludwig H; Zojer N
    J Cancer Res Clin Oncol; 2012 Nov; 138(11):1821-30. PubMed ID: 22722711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preconditioning with interleukin-1 beta and interferon-gamma enhances the efficacy of human umbilical cord blood-derived mesenchymal stem cells-based therapy via enhancing prostaglandin E2 secretion and indoleamine 2,3-dioxygenase activity in dextran sulfate sodium-induced colitis.
    Yu Y; Yoo SM; Park HH; Baek SY; Kim YJ; Lee S; Kim YL; Seo KW; Kang KS
    J Tissue Eng Regen Med; 2019 Oct; 13(10):1792-1804. PubMed ID: 31293088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NLGP counterbalances the immunosuppressive effect of tumor-associated mesenchymal stem cells to restore effector T cell functions.
    Ghosh T; Nandi P; Ganguly N; Guha I; Bhuniya A; Ghosh S; Sarkar A; Saha A; Dasgupta S; Baral R; Bose A
    Stem Cell Res Ther; 2019 Sep; 10(1):296. PubMed ID: 31547863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stromal cell plasticity and the tumor microenvironment.
    Bae HJ; Liu S; Jin P; Stroncek D
    Emerg Top Life Sci; 2017 Dec; 1(5):487-492. PubMed ID: 33525796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.
    Luz-Crawford P; Kurte M; Bravo-Alegría J; Contreras R; Nova-Lamperti E; Tejedor G; Noël D; Jorgensen C; Figueroa F; Djouad F; Carrión F
    Stem Cell Res Ther; 2013 Jun; 4(3):65. PubMed ID: 23734780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similarities between Tumour Immune Response and Chronic Wound Microenvironment: Influence of Mesenchymal Stromal/Stem Cells.
    Peta KT; Ambele MA; Pepper MS
    J Immunol Res; 2021; 2021():6649314. PubMed ID: 33860061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indoleamine 2,3-dioxygenase mediates inhibition of virus-specific CD8(+) T cell proliferation by human mesenchymal stromal cells.
    Hong J; Hueckelhoven A; Wang L; Schmitt A; Wuchter P; Tabarkiewicz J; Kleist C; Bieback K; Ho AD; Schmitt M
    Cytotherapy; 2016 May; 18(5):621-9. PubMed ID: 27008974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indoleamine 2, 3-Dioxgenase Transfected Mesenchymal Stem Cells Induce Kidney Allograft Tolerance by Increasing the Production and Function of Regulatory T Cells.
    He Y; Zhou S; Liu H; Shen B; Zhao H; Peng K; Wu X
    Transplantation; 2015 Sep; 99(9):1829-38. PubMed ID: 26308414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory effects of mesenchymal stromal cells-derived exosome.
    Chen W; Huang Y; Han J; Yu L; Li Y; Lu Z; Li H; Liu Z; Shi C; Duan F; Xiao Y
    Immunol Res; 2016 Aug; 64(4):831-40. PubMed ID: 27115513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Indoleamine 2,3 Dioxygenase Inhibitor on the Cytotoxic Activity of Tumour-infiltrating Lymphocytes.
    Le Naour S; Knol AC; Pandolfino MC; Khammari A; Dréno B
    Acta Derm Venereol; 2019 Nov; 99(12):1186-1187. PubMed ID: 31408178
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunomodulatory effects of bone marrow-derived mesenchymal stem cells on pro-inflammatory cytokine-stimulated human corneal epithelial cells.
    Wen L; Zhu M; Madigan MC; You J; King NJ; Billson FA; McClellan K; Sutton G; Petsoglou C
    PLoS One; 2014; 9(7):e101841. PubMed ID: 25003339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritumoral indoleamine 2,3-dioxygenase expression in melanoma: an early marker of resistance to immune control?
    Chevolet I; Speeckaert R; Haspeslagh M; Neyns B; Krüse V; Schreuer M; Van Gele M; Van Geel N; Brochez L
    Br J Dermatol; 2014 Nov; 171(5):987-95. PubMed ID: 24814041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The paracrine immunomodulatory interactions between the human dental pulp derived mesenchymal stem cells and CD4 T cell subsets.
    Özdemir AT; Özgül Özdemir RB; Kırmaz C; Sarıboyacı AE; Ünal Halbutoğlları ZS; Özel C; Karaöz E
    Cell Immunol; 2016 Dec; 310():108-115. PubMed ID: 27576175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.